lost weight on semaglutide but not tirzepatide and Loss Program in Houston at Amerejuve MedSpa Semaglutide vs Tirzepatide: Biomarker-Guided Selection

COA / Lab results Evidence: Clinical trial Pros Triple GLP-1 / GIP / glucagon agonism in one peptide raises energy expenditure, not appetite alone Largest weight reduction reported for an incretin-class compound (~24% at 12 mg, 48-wk phase 2) Reductions in HbA1c, visceral fat and liver-fat content across trials Once-weekly subcutaneous dosing (albumin-bound half-life) Cons GI effects require gradual multi-week dose titration Newest of the GLP-1 class phase 3 (TRIUMPH) topline only

Luo G, et al

PEPTIS 2026 OWIADCZENIE: RESEARCH USE ONLY (RUO) Produkt jest odczynnikiem chemicznym przeznaczonym wycznie do bada laboratoryjnych, analitycznych oraz celw dydaktycznych

We selected reviews, clinical trials, and basic research articles from the past 5 years

Look, genes do work

A nonprofit health plan complains that the health system is asking for a 70% rate increase